Status:
COMPLETED
Mask Ventilation Before and After Neuromuscular Blockade
Lead Sponsor:
University of Washington
Conditions:
Anesthesia
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Anesthesia providers are taught to "test" that they can properly ventilate a patient's lungs before administering a neuromuscular blocking drug (NMBD), rendering the patient apneic. This is a traditio...
Detailed Description
The following will be carried out per routine standard of care: The patient will be met in the pre-operative area by the attending anesthesiologist who interviews and examines the patient. A full exp...
Eligibility Criteria
Inclusion
- Patients who are 18 years or greater
- Present for elective surgery and
- Require placement of a breathing tube for their surgery
Exclusion
- Patients will not be eligible if they are pregnant
- Are a minor
- Are a prisoner
- Have impaired decision-making capacity
- Have symptomatic untreated reflux
- Prior esophagectomy or hiatal hernia
- Vomiting within 24 hours of surgery
- Known oral or facial pathology making a proper mask fit unlikely
- Any condition for which the primary anesthesia team deems a rapid-sequence intubation to be appropriate
- Prior allergy or contraindication to receiving rocuronium, vecuronium, or succinylcholine.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT02237443
Start Date
August 1 2014
End Date
February 1 2015
Last Update
April 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harborview Medical Center
Seattle, Washington, United States, 98104